Arthritis
Researchers from University of Amsterdam describe findings in arthritis
Published in Proteomics Weekly, March 24th, 2008
According to recent research published in the journal Arthritis and Rheumatism, "Atacicept is a recombinant fusion protein that binds and neutralizes B lymphocyte stimulator and a proliferation-inducing ligand. The purpose of this study was to investigate the tolerability, pharmacokinetics, and pharmacodynamics of atacicept treatment in patients with rheumatoid arthritis (RA) and to collect exploratory data on clinical outcomes."
"In this multicenter, phase Ib, randomized, placebo-controlled, dose-escalating trial, 73 patients were enrolled into 6 escalating-dose cohorts. Patients received atacicept or placebo as single doses (70, 210, or 630 mg) or as repeated...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Proteomics Weekly
Source: Proteomics Weekly (2008-03-24)
More Articles from Proteomics Weekly
- Breast Cancer
Late treatment with letrozole can reduce breast cancer recurrence risk - Crohn Disease
Caspase-12: MUHC researcher finds new defense mechanism against intestinal inflammation - Enzyme Research
Alcohol consumption and polymorphisms of cytochromes P4502E1 are high risks for ESCC - Cancer
Power3 Medical Products Inc. Publishes Discovery of Protein Biomarkers for Esophageal Malignancies in the International Journal of Cancer - Corynebacterium
Researchers from University of Murcia report recent findings in Corynebacterium - DNA Research
Research from Kyushu University has provided new information about DNA research - More from this issue of Proteomics Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
